Probiotics for the prevention of antibiotic-associated diarrhea in outpatients—A systematic review and meta-analysis

Antibiotics

Volumn 6, Issue 4, 2017, Pages

  Blaabjerg, Sara ^a   Artzi, Daniel Maribo ^a   Aabenhus, Rune ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antibiotic associated diarrhea; Bifidobacterium; Lactobacillus; Primary care; Probiotics; Saccharomyces

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT;

ANTIBIOTIC ASSOCIATED DIARRHEA; BACILLUS SUBTILIS; BIFIDOBACTERIUM; CLOSTRIDIUM; CLOSTRIDIUM BUTYRICUM; DISPERSITY; EPIGASTRIC DISCOMFORT; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; INCIDENCE; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LEUCONOSTOC; LOSS OF APPETITE; LOWER RESPIRATORY TRACT INFECTION; META ANALYSIS; METALLIC TASTE; NAUSEA; NONHUMAN; OUTPATIENT; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SACCHAROMYCES; SACCHAROMYCES BOULARDII; STREPTOCOCCUS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 85033478310     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics6040021     Document Type: Review

References (34)

1. McFarland, L.V. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig. Dis. (Basel Switz.) 1998, 16, 292–307.
2. Wistrom, J.; Norrby, S.R.; Myhre, E.B.; Eriksson, S.; Granstrom, G.; Lagergren, L.; Englund, G.; Nord, C.E.; Svenungsson, B. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: A prospective study. J. Antimicrob. Chemother. 2001, 47, 43–50.
3. Goossens, H.; Ferech, M.; Vander Stichele, R.; Elseviers, M. Outpatient antibiotic use in Europe and association with resistance: A cross-national database study. Lancet (Lond. Engl.) 2005, 365, 579–587.
4. Food and Agriculture Organization of the United Nation/World Health Organization. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food; FAO/WHO: London, ON, Canada, 2002.
5. Rolfe, R.D. The role of probiotic cultures in the control of gastrointestinal health. J. Nutr. 2000, 130, 396s–402s.
6. Goldenberg, J.Z.; Lytvyn, L.; Steurich, J.; Parkin, P.; Mahant, S.; Johnston, B.C. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev. 2015, Cd004827, doi:10.1002/14651858.CD004827.
7. Tankanow, R.M.; Ross, M.B.; Ertel, I.J.; Dickinson, D.G.; McCormick, L.S.; Garfinkel, J.F. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP 1990, 24, 382–384.
8. Vanderhoof, J.A.; Whitney, D.B.; Antonson, D.L.; Hanner, T.L.; Lupo, J.V.; Young, R.J. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J. Pediatr. 1999, 135, 564–568.
9. Arvola, T.; Laiho, K.; Torkkeli, S.; Mykkanen, H.; Salminen, S.; Maunula, L.; Isolauri, E. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatrics 1999, 104, e64, doi:10.1542/peds.104.5.e64.
10. Erdeve, O.; Tiras, U.; Dallar, Y. The probiotic effect of Saccharomyces boulardii in a pediatric age group. J. Trop. Pediatr. 2004, 50, 234–236.
11. Duman, D.G.; Bor, S.; Ozutemiz, O.; Sahin, T.; Oguz, D.; Istan, F.; Vural, T.; Sandkci, M.; Işksal, F.; Simşek, I., et al. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. Eur. J. Gastroenterol. Hepatol. 2005, 17, 1357–1361.
12. Park, S.K.; Park, D.I.; Choi, J.S.; Kang, M.S.; Park, J.H.; Kim, H.J.; Cho, Y.K.; Sohn, C.I.; Jeon, W.K.; Kim, B.I. The effect of probiotics on Helicobacter pylori eradication. Hepatogastroenterology 2007, 54, 2032–2036.
13. Cindoruk, M.; Erkan, G.; Karakan, T.; Dursun, A.; Unal, S. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study. Helicobacter 2007, 12, 309–316.
14. Conway, S.; Hart, A.; Clark, A.; Harvey, I. Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice. Br. J. Gen. Pract. 2007, 57, 953–959.
15. Imase, K.; Takahashi, M.; Tanaka, A.; Tokunaga, K.; Sugano, H.; Tanaka, M.; Ishida, H.; Kamiya, S.; Takahashi, S. Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota. Microbiol. Immunol. 2008, 52, 156–161.
16. Kim, M.N.; Kim, N.; Lee, S.H.; Park, Y.S.; Hwang, J.H.; Kim, J.W.; Jeong, S.H.; Lee, D.H.; Kim, J.S.; Jung, H.C., et al. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter 2008, 13, 261–268.
17. Merenstein, D.J.; Foster, J.; D’Amico, F. A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: The measuring the influence of Kefir (MILK) Study. Arch. Pediatr. Adolesc. Med. 2009, 163, 750–754.
18. De Vrese, M.; Kristen, H.; Rautenberg, P.; Laue, C.; Schrezenmeir, J. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J. Dairy Res. 2011, 78, 396–403.
19. Ojetti, V.; Bruno, G.; Ainora, M.E.; Gigante, G.; Rizzo, G.; Roccarina, D.; Gasbarrini, A. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. Gastroenterol. Res. Pract. 2012, 2012, 740381, doi:10.1155/2012/740381
20. Chatterjee, S.; Kar, P.; Das, T.; Ray, S.; Gangulyt, S.; Rajendiran, C.; Mitra, M. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea. J. Assoc. Phys. India 2013, 61, 708–712.
21. Zojaji, H.; Ghobakhlou, M.; Rajabalinia, H.; Ataei, E.; Jahani Sherafat, S.; Moghimi-Dehkordi, B.; Bahreiny, R. The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: A randomized controlled trial. Gastroenterol. Hepatol. Bed. Bench 2013, 6, S99–S104.
22. Fox, M.J.; Ahuja, K.D.; Robertson, I.K.; Ball, M.J.; Eri, R.D. Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study. BMJ Open 2015, 5, e006474, doi:10.1136/bmjopen-2014-006474.
23. Olek, A.; Woynarowski, M.; Ahren, I.L.; Kierkus, J.; Socha, P.; Larsson, N.; Önning, G. Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic-Associated Gastrointestinal Symptoms in Children-Randomized, Double-Blind, Placebo-Controlled Study. J. Pediatr. 2017, 186, 82–86.
24. WHO. Diarrhoeal Disease. Available online: http://www.who.int/mediacentre/factsheets/fs330/en/ (accessed on 1 June 2017).
25. Ouwehand, A.C. A review of dose-responses of probiotics in human studies. Benef. Microbes 2016, 8, 143–151.
26. Hempel, S.; Newberry, S.J.; Maher, A.R.; Wang, Z.; Miles, J.N.; Shanman, R.; Johnsen, B.; Shekelle, P.G. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis. JAMA 2012, 307, 1959–1969.
27. Petersen, I.; Hayward, A.C. Antibacterial prescribing in primary care. J. Antimicrob. Chemother. 2007, 60, i43–i47.
28. Hempel, S.; Newberry, S.; Ruelaz, A.; Wang, Z.; Miles, J.N.; Suttorp, M.J.; Johnsen, B.; Shanman, R.; Slusser, W.; Fu, N., et al. Safety of probiotics used to reduce risk and prevent or treat disease. Evid. Rep./Technol. Assess. 2011, 1–645.
29. WHO. Appendix 1, Definitions of health-care settings and other related terms. In Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care; World Health Organization: Geneva, Switzerland, 2009. Available online: https://www.ncbi.nlm.nih.gov/books/NBK144006/ (accessed on 1 June 2017).
30. Higgins, J.P.T. Cochrane Handbook for Systematic Reviews of Interventions, Chapter 8: Assessing Risk of Bias in Included Studies; Higgins, J.P.T., Green, S., Eds.; John Wiley & Sons: Chichester, UK, 2008.
31. The GRADE Working Group. GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations; Schünemann, H., Brożek, J., Guyatt, G., Oxman, A., Eds.; Updated October 2013. The GRADE Working Group, 2013. Available online: https://gdt.gradepro.org/app/handbook/handbook.html (accessed on 1 June 2017).
32. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (Developed by Evidence Prime, Inc.). Available online: https://gradepro.org./ (accessed on 5 October 2017).
33. Review Manager (RevMan) [Computer program]. Version 5.3; The Nordic Cochrane Centre: The Cochrane Collaboration: Copenhagen, Denmark, 2014.
34. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]; Higgins, J.P.T., Green, S., Eds.; The Cochrane Collaboration: Copenhagen, Denmark, 2011. Available online: www.handbook.cochrane.org (accessed on 1 June 2017).